University of California, San Francisco
Claim this profileSummary
University of California, San Francisco is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Prostate Cancer, Brain Tumor, Breast Cancer, Solid Tumors and other specialties. University of California, San Francisco is involved with conducting 2,330 clinical trials across 2,509 conditions. There are 312 research doctors associated with this hospital, such as Rahul Aggarwal, MD, Sabine Mueller, MD, PhD, MAS, Kieuhoa T. Vo, and Hope Rugo, MD.Area of expertise
Cancer
University of California, San Francisco has run 181 trials for Cancer. Some of their research focus areas include:
Prostate Cancer
University of California, San Francisco has run 132 trials for Prostate Cancer. Some of their research focus areas include:
Top PIs
Rahul Aggarwal, MD
University of California, San Francisco
6 years of reported clinical research
Sabine Mueller, MD, PhD, MAS
University of California, San Francisco
1 year of reported clinical research
Kieuhoa T. Vo
UCSF Medical Center-Mission Bay
4 years of reported clinical research
Hope Rugo, MD
University of California San Francisco
5 years of reported clinical research
Clinical Trials running at University of California, San Francisco
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting
2 awards
Phase 3
6 criteria
RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant
for Breast Cancer
This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.
Recruiting
2 awards
Phase 3
5 criteria
Tamoxifen + Letrozole
for Fertility Preservation in Breast Cancer
This trial is testing two medication combinations to help women with breast cancer preserve their fertility. It focuses on women with a specific type of breast cancer and aims to find out which combination helps produce more mature eggs. The medications work by managing hormone levels and stimulating the ovaries. Tamoxifen and letrozole have been used to safely manage hormone levels in breast cancer patients undergoing fertility preservation.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of California, San Francisco?
University of California, San Francisco is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Prostate Cancer, Brain Tumor, Breast Cancer, Solid Tumors and other specialties. University of California, San Francisco is involved with conducting 2,330 clinical trials across 2,509 conditions. There are 312 research doctors associated with this hospital, such as Rahul Aggarwal, MD, Sabine Mueller, MD, PhD, MAS, Kieuhoa T. Vo, and Hope Rugo, MD.
Where is University of California, San Francisco located?
To reach the University of California, San Francisco hospital: - Take the SF Muni "T" line towards Sunnyside, disembarking at the UCSF Mission Bay station. - Alternatively, catch the UCSF "Red" Shuttle from the BART Mission & 16th Street Station, available every 10-15 minutes, Monday-Friday, 6:00 am - 7:50 pm. - The hospital's address is 505 Parnassus Ave, San Francisco, CA, US.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at UCSF Hospital: - **Billing:** (866) 433-4035 - **Financial Counseling:** (415) 353-1966 - **Health Insurance:** (415) 353-3333 or (866) 433-4035 These contacts can help with understanding statements, arranging payment plans, and offering financial assistance for qualifying individuals. Visit the UCSF Health website for more details.
What insurance does University of California, San Francisco accept?
The University of California, San Francisco (UCSF) accepts a variety of insurance plans, including HMO plans through Kaiser Permanente, PPO plans through Anthem Blue Cross, Medicare Advantage, and Medi-Cal programs. For employees, UCSF offers medical plans such as Kaiser (HMO), UC Blue & Gold (Health Net), UC Care, UC Health Savings Plan, and CORE (all administered by Anthem Blue Cross). It is crucial to verify with your insurance company or employer's benefit manager for specific plan access to UCSF's services.
What awards or recognition has University of California, San Francisco received?
The University of California, San Francisco (UCSF) hospital is globally recognized for its innovative treatments, advanced technology, and pioneering research in patient care. It is consistently ranked among the top hospitals in the U.S. and California, with several nationally ranked programs for adults and children. UCSF Health has achieved Magnet recognition for nursing excellence since 2012 and is home to five Nobel Prize winners, underscoring its significant contributions to health sciences research.